Theragenics Launches Antibacterial Suture for the Veterinary Market
Innovative Addition to our CP Medical Veterinary Products May 1, 2013 11:07 UTC BUFORD, Ga.–(BUSINESS WIRE)–Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that CP Medical (a wholly-owned subsidiary of Theragenics) launched its “PLUS” line of antibacterial sutures for use in the veterinary market. […]
Theragenics Launches Antibacterial Suture for the Veterinary Market Read More »
